{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:35:31Z","timestamp":1786545331647,"version":"build-2736575974"},"reference-count":42,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Influenza Resp Viruses"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Influenza causes 650,000 deaths, 3\u20135 million hospitalizations, and 1 billion cases worldwide each year. There is a limited repertoire of antivirals available to tackle this burden, highlighting the risk of developing resistance to current drugs. An effort to develop new influenza antivirals has been made, leading to the approval of baloxavir. Some mutations leading to reduced susceptibility to baloxavir have been reported, but information about their epidemiology is scarce. Thus, we aim to evaluate the prevalence of substitutions in the polymerase acidic (PA) subunit associated with baloxavir susceptibility over 16 epidemiological seasons in Europe.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We evaluated 87,266 sequences collected from 2009 to 2025 in Europe, annotated the mutations, and identified all known amino acid substitutions related to changes in baloxavir susceptibility to assess their prevalence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 149 (0.2%) sequences with at least one substitution were identified, 81 (0.09%) exhibiting reduced susceptibility. Overall, 17 different substitutions were detected, located both inside and outside baloxavir binding site. The number of substitutions detected ranged from 0 to 15 per season, with E23K, E23R, K34R, A36V, I38F, I38L, and E120D emerging after baloxavir approval in Europe. Double and triple concurrent substitutions were also identified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>While the prevalence of sequences with substitutions that alter baloxavir susceptibility remains stable, the number of circulating substitutions increases over time. This implies the emergence of amino acid substitutions that did not circulate before and the concurrence of double and triple substitutions that might synergize their individual effects. These results highlight the need for virological surveillance and novel antiviral treatments.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/irv.70288","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T09:08:42Z","timestamp":1782464922000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Sequence\u2010Based Update on Amino Acid Substitutions in Influenza Polymerase Acidic Protein in Europe That Alter Baloxavir Susceptibility From 2009 to 2025"],"prefix":"10.1111","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7664-4433","authenticated-orcid":false,"given":"Alejandro","family":"Mart\u00edn\u2010Toribio","sequence":"first","affiliation":[{"name":"National Influenza Centre  Valladolid Spain"},{"name":"Fundaci\u00f3n Instituto de Estudios de Ciencias de la Salud de Castilla y Le\u00f3n  Soria Spain"},{"name":"Microbiology Area, Faculty of Medicine University of Valladolid  Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e9s","family":"Inchausti\u2010Moya","sequence":"additional","affiliation":[{"name":"Microbiology Section, Departamento de Ciencias, Farmac\u00e9uticas y de la Salud, Facultad de Farmacia Universidad San Pablo\u2010CEU, CEU Universities  Madrid Spain"},{"name":"Institute of Applied Molecular Medicine Nemesio Diez (IMMA\u2010ND), Department of Basic Medical Sciences, Facultad de Medicina Universidad San Pablo\u2010CEU, CEU Universities  Boadilla del Monte Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Toquero\u2010Asensio","sequence":"additional","affiliation":[{"name":"National Influenza Centre  Valladolid Spain"},{"name":"Fundaci\u00f3n Instituto de Estudios de Ciencias de la Salud de Castilla y Le\u00f3n  Soria Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Garc\u00eda\u2010D\u00edaz","sequence":"additional","affiliation":[{"name":"National Influenza Centre  Valladolid Spain"},{"name":"Hospital Cl\u00ednico Universitario de Valladolid  Valladolid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Sanchez\u2010Martinez","sequence":"additional","affiliation":[{"name":"National Influenza Centre  Valladolid Spain"},{"name":"Fundaci\u00f3n Instituto de Estudios de Ciencias de la Salud de Castilla y Le\u00f3n  Soria Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Rodriguez\u2010Crespo","sequence":"additional","affiliation":[{"name":"National Influenza Centre  Valladolid Spain"},{"name":"Fundaci\u00f3n Instituto de Estudios de Ciencias de la Salud de Castilla y Le\u00f3n  Soria Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Galindo\u2010Carretero","sequence":"additional","affiliation":[{"name":"National Influenza Centre  Valladolid Spain"},{"name":"Fundaci\u00f3n Instituto de Estudios de Ciencias de la Salud de Castilla y Le\u00f3n  Soria Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Iglesia\u2010Aparicio","sequence":"additional","affiliation":[{"name":"National Influenza Centre  Valladolid Spain"},{"name":"Fundaci\u00f3n Instituto de Estudios de Ciencias de la Salud de Castilla y Le\u00f3n  Soria Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Lopez\u2010Gonzalo","sequence":"additional","affiliation":[{"name":"National Influenza Centre  Valladolid Spain"},{"name":"Fundaci\u00f3n Instituto de Estudios de Ciencias de la Salud de Castilla y Le\u00f3n  Soria Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Ant\u00f3n\u2010Contreras","sequence":"additional","affiliation":[{"name":"National Influenza Centre  Valladolid Spain"},{"name":"Fundaci\u00f3n Instituto de Estudios de Ciencias de la Salud de Castilla y Le\u00f3n  Soria Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Rojo\u2010Rello","sequence":"additional","affiliation":[{"name":"National Influenza Centre  Valladolid Spain"},{"name":"Microbiology Area, Faculty of Medicine University of Valladolid  Spain"},{"name":"Hospital Cl\u00ednico Universitario de Valladolid  Valladolid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Dominguez\u2010Gil","sequence":"additional","affiliation":[{"name":"National Influenza Centre  Valladolid Spain"},{"name":"Microbiology Area, Faculty of Medicine University of Valladolid  Spain"},{"name":"Hospital Universitario Rio Hortega  Valladolid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6914-9987","authenticated-orcid":false,"given":"Marta","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[{"name":"National Influenza Centre  Valladolid Spain"},{"name":"Microbiology Area, Faculty of Medicine University of Valladolid  Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5357-6340","authenticated-orcid":false,"given":"Jose M.","family":"Eiros","sequence":"additional","affiliation":[{"name":"National Influenza Centre  Valladolid Spain"},{"name":"Microbiology Area, Faculty of Medicine University of Valladolid  Spain"},{"name":"Hospital Cl\u00ednico Universitario de Valladolid  Valladolid Spain"},{"name":"Hospital Universitario Rio Hortega  Valladolid Spain"},{"name":"Centro de Investigaciones Biomedicas en Red en Enfermedades Infecciosas (CIBERINFEC)  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estanislao","family":"Nistal\u2010Villan","sequence":"additional","affiliation":[{"name":"Microbiology Section, Departamento de Ciencias, Farmac\u00e9uticas y de la Salud, Facultad de Farmacia Universidad San Pablo\u2010CEU, CEU Universities  Madrid Spain"},{"name":"Institute of Applied Molecular Medicine Nemesio Diez (IMMA\u2010ND), Department of Basic Medical Sciences, Facultad de Medicina Universidad San Pablo\u2010CEU, CEU Universities  Boadilla del Monte Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"Sanz\u2010Mu\u00f1oz","sequence":"additional","affiliation":[{"name":"National Influenza Centre  Valladolid Spain"},{"name":"Fundaci\u00f3n Instituto de Estudios de Ciencias de la Salud de Castilla y Le\u00f3n  Soria Spain"},{"name":"Centro de Investigaciones Biomedicas en Red en Enfermedades Infecciosas (CIBERINFEC)  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(17)33293\u20102"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.13.04003"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12504"},{"key":"e_1_2_10_5_1","doi-asserted-by":"crossref","unstructured":"Y.Gao M.Liu T. M.Uyeki et\u00a0al. \u201cRisk Factors for Hospitalization and Mortality in Patients With Influenza Virus Infection: A Systematic Review and Meta\u2010Analysis \u201dSocial Science Research Network. Preprint posted online May 13 2025:5247981 https:\/\/doi.org\/10.2139\/ssrn.5247981.","DOI":"10.2139\/ssrn.5247981"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen\u20102025\u2010106332"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572\u2010018\u20100002\u2010y"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2022.105499"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2017.0141"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119115"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2014.04.009"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2024.2429627"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.01401\u201010"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2666\u20105247(24)00037\u20105"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid3007.240480"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2025.199599"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560\u20107917.ES.2025.30.48.2500873"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.3390\/v16071109"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2018.10.008"},{"key":"e_1_2_10_20_1","unstructured":"T.Shishido T.Noshi A.Yamamoto andM.Kitano \u201cMedicine for Treating Influenza Characterized by Comprising Combination of Cap\u2010Dependent Endonuclease Inhibitor With Anti\u2010Influenza Drug \u201d Published online June 22 (2017) accessed October 24 2025 https:\/\/patentscope.wipo.int\/search\/en\/WO2017104691."},{"key":"e_1_2_10_21_1","unstructured":"\u201cDrug Approval Package: Xofluza Film\u2010Coated Tablets (Baloxavir Marboxil) \u201d (2018) accessed January 21 2026 https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2018\/210854Orig1s000TOC.cfm."},{"key":"e_1_2_10_22_1","unstructured":"\u201cReport on the Deliberation Results (PMDA): Xofluza Tablets 10 mg \u201d (2018) https:\/\/www.pmda.go.jp\/files\/000225380.pdf."},{"key":"e_1_2_10_23_1","unstructured":"\u201cXofluza|European Medicines Agency (EMA) \u201d January 22 (2021) accessed January 21 2026 https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/xofluza."},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010698"},{"key":"e_1_2_10_25_1","unstructured":"World Health Organization \u201cSummary of Polymerase Acidic Protein (PA) Amino Acid Substitutions Assessed for Their Effects on PA Inhibitor (PAI) Baloxavir Susceptibility \u201d (2024). Accessed April 30 2026 https:\/\/cdn.who.int\/media\/docs\/default\u2010source\/influenza\/laboratory\u2010\u2010\u2010network\/quality\u2010assurance\/antiviral\u2010susceptibility\u2010influenza\/pa\u2010marker\u2010who\u2010table_28\u201011\u20102025_updated.pdf."},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2025.106217"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2021.105158"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2022.105281"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/gch2.1018"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40780\u2010023\u201000274\u20101"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560\u20107917.ES.2026.31.1.2500336"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598\u2010018\u201027890\u20104"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2025.106299"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa527"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz245"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz244"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biochem.3c00536"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00705\u2010023\u201005958\u20105"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid3104.241820"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2021.105126"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473\u20103099(21)00469\u20102"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaf439"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2666\u20105247(24)00066\u20101"}],"container-title":["Influenza and Other Respiratory Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/irv.70288","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/irv.70288","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/irv.70288","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:39:52Z","timestamp":1786541992000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/irv.70288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1111\/irv.70288"],"URL":"https:\/\/doi.org\/10.1111\/irv.70288","archive":["Portico"],"relation":{},"ISSN":["1750-2640","1750-2659"],"issn-type":[{"value":"1750-2640","type":"print"},{"value":"1750-2659","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"2026-03-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70288"}}